Guobo Xie

670 total citations
30 papers, 372 citations indexed

About

Guobo Xie is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Guobo Xie has authored 30 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Epidemiology. Recurrent topics in Guobo Xie's work include Liver Disease Diagnosis and Treatment (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Heart Failure Treatment and Management (8 papers). Guobo Xie is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Heart Failure Treatment and Management (8 papers). Guobo Xie collaborates with scholars based in China. Guobo Xie's co-authors include Yang Zou, Yanjia Zhong, Guotai Sheng, Maobin Kuang, Shuo Yang, Rongsheng Wang, Yu Meng, Ruijuan Yang, Song Lu and Huimin Zhang and has published in prestigious journals such as PLoS ONE, Journal of Translational Medicine and Frontiers in Endocrinology.

In The Last Decade

Guobo Xie

20 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guobo Xie China	10	200	175	89	66	53	30	372
Yanjia Zhong China	8	249 1.2×	166 0.9×	91 1.0×	108 1.6×	51 1.0×	8	398
D Sinagra Italy	9	132 0.7×	130 0.7×	67 0.8×	31 0.5×	46 0.9×	25	323
Rongjiong Zheng China	6	159 0.8×	122 0.7×	117 1.3×	32 0.5×	21 0.4×	12	315
Kyeong Hye Park South Korea	10	167 0.8×	81 0.5×	32 0.4×	88 1.3×	32 0.6×	21	378
Ting-Yao Wang Taiwan	9	116 0.6×	247 1.4×	48 0.5×	73 1.1×	32 0.6×	22	385
Jen Jung Pan United States	6	105 0.5×	214 1.2×	31 0.3×	104 1.6×	37 0.7×	6	343
Beniamino Zalunardo Italy	5	141 0.7×	215 1.2×	52 0.6×	87 1.3×	32 0.6×	11	310
Sailimai Man China	9	57 0.3×	117 0.7×	41 0.5×	49 0.7×	30 0.6×	28	255
Lui Li China	5	292 1.5×	472 2.7×	79 0.9×	74 1.1×	42 0.8×	8	557
Sakura Yamamura Japan	7	260 1.3×	520 3.0×	64 0.7×	48 0.7×	78 1.5×	8	551

Countries citing papers authored by Guobo Xie

Since Specialization

Citations

This map shows the geographic impact of Guobo Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobo Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobo Xie more than expected).

Fields of papers citing papers by Guobo Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobo Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobo Xie. The network helps show where Guobo Xie may publish in the future.

Co-authorship network of co-authors of Guobo Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Guobo Xie. A scholar is included among the top collaborators of Guobo Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobo Xie. Guobo Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Chao, Guobo Xie, Zhiyu Xiong, et al.. (2025). Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovascular Diabetology. 24(1). 431–431.

Hu, Lin, Chuanjin Liu, Xinfang Huang, et al.. (2025). Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study. Frontiers in Endocrinology. 16. 1627821–1627821.

Xie, Guobo, et al.. (2025). Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity?. Lipids in Health and Disease. 25(1). 33–33.

Jian, Guihua, Zhihong Lu, Lin Xie, et al.. (2025). Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China. Frontiers in Endocrinology. 16. 1624112–1624112.

Peng, Nan, Maobin Kuang, Xin Huang, et al.. (2025). The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD. BMC Gastroenterology. 25(1). 236–236. 1 indexed citations

Qiu, Jiajun, Maobin Kuang, Chao Wang, et al.. (2024). Evaluating the Prognostic Value of Systemic Immune-Inflammatory Index in Patients with Acute Decompensated Heart Failure. ESC Heart Failure. 11(5). 3133–3145. 5 indexed citations

Kuang, Maobin, Jiajun Qiu, Ruijuan Yang, et al.. (2024). Prognostic value of geriatric nutritional risk index in patients with stable coronary artery disease undergoing percutaneous coronary intervention. BMC Cardiovascular Disorders. 24(1). 264–264. 2 indexed citations

Wang, Chao, Xin Huang, Maobin Kuang, et al.. (2024). The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective. Lipids in Health and Disease. 23(1). 311–311. 1 indexed citations

Xie, Lin, Qun Wang, Maobin Kuang, et al.. (2024). The systemic inflammation response index as a significant predictor of short-term adverse outcomes in acute decompensated heart failure patients: a cohort study from Southern China. Frontiers in Endocrinology. 15. 1444663–1444663.

10.

Yang, Hongyi, Maobin Kuang, Jiajun Qiu, et al.. (2024). Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure. Frontiers in Endocrinology. 15. 1393644–1393644. 4 indexed citations

11.

Sheng, Guotai, Jiajun Qiu, Maobin Kuang, et al.. (2023). Assessing temporal differences of baseline body mass index, waist circumference, and waist-height ratio in predicting future diabetes. Frontiers in Endocrinology. 13. 1020253–1020253. 9 indexed citations

12.

Li, Xinghui, Huijian Yang, Guobo Xie, et al.. (2023). Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study. Frontiers in Cardiovascular Medicine. 10. 1266879–1266879. 2 indexed citations

13.

Kuang, Maobin, Ruijuan Yang, Xin Huang, et al.. (2023). Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes: an analysis using time-dependent receiver operating characteristics. Journal of Translational Medicine. 21(1). 299–299. 33 indexed citations

14.

Lu, Song, Maobin Kuang, Chong Hu, et al.. (2023). Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. Journal of Translational Medicine. 21(1). 192–192. 42 indexed citations

15.

Peng, Nan, Maobin Kuang, Hang Yu, et al.. (2023). Associations between TyG-BMI and normal-high blood pressure values and hypertension: cross-sectional evidence from a non-diabetic population. Frontiers in Cardiovascular Medicine. 10. 1129112–1129112. 14 indexed citations

16.

Kuang, Maobin, Ruijuan Yang, Nan Peng, et al.. (2023). The role of predicted lean body mass and fat mass in non-alcoholic fatty liver disease in both sexes: Results from a secondary analysis of the NAGALA study. Frontiers in Nutrition. 10. 1103665–1103665. 2 indexed citations

17.

Xie, Guobo, Yanjia Zhong, Shuo Yang, & Yang Zou. (2021). Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4735–4745. 41 indexed citations

18.

Wang, Rongsheng, et al.. (2021). Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids in Health and Disease. 20(1). 77–77. 60 indexed citations

19.

Zou, Yang, et al.. (2021). Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids in Health and Disease. 20(1). 139–139. 38 indexed citations

20.

Xie, Guozhu, Jie Lin, Lanfang Zhang, et al.. (2018). Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy. Journal for ImmunoTherapy of Cancer. 6(1). 88–88. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact